Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8 + T cells from B-CLL patients: Impact on clonal B-cell apoptosis

British Journal of Haematology

Volumn 112, Issue 3, 2001, Pages 760-767

  Kay, Neil E ^a   Han, Lei ^b   Bone, Nancy ^a   Williams, Gary ^c  

^a MAYO CLINIC   (United States)

^b Virginia Piper Cancer Institute   (United States)

^c BAYER AG   (Germany)

Author keywords

Apoptosis; B cells; B CLL; IL 4; T cells

Indexed keywords

FLUDARABINE; INTERLEUKIN 4; INTERLEUKIN 4 ANTIBODY; INTERLEUKIN 4 RECEPTOR;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SUPERNATANT; T LYMPHOCYTE SUBPOPULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; HUMANS; INTERLEUKIN-4; LEUKEMIA, B-CELL, CHRONIC; VIDARABINE;

EID: 0035106335     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02605.x     Document Type: Article

References (45)

1. Impairments in immune cell function in B cell chronic lymphocytic leukemia
2. Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia
3. Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of Bcl-2 modulation or dependence on functional p53
4. Interferon-alpha-mediated prevention of in vitro apoptosis of chronic lymphocytic leukemia B cells: Role of Bcl-2 and c-myc
5. Interluekin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis
6. Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro
7. Interleukin-4 protects chronic lymphocytic leukemic B cells from death by apoptosis and up-regulates Bcl-2 expression
8. + T cell subset in B-cell chronic lymphocytic leukaemia
9. Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta
10. Interluekin-10 (IL-10) up-regulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes
11. Interleukin-10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells
12. Protection from apoptotic cell death by interleukin-4 is increased in previously treated chronic lymphocytic leukemia patients
13. Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations
14. Pharmacokinetic study of fludarabine phosphate (NSC 312887)
15. Action of 9-beta-D-arabinofuranosyl-2 fluoroadenine on RNA metabolism
16. IL-13 expression at the sites of allergen challenge in patients with asthma
17. Interferon-alpha, Bcl-2 expression and apoptosis in B-cell chronic lymphocytic leukemia
18. Interferon-alpha up-regulates Bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo
19. The cellular biology of B-cell chronic lymphocytic leukemia
20. Cytoplasmic interleukin-4 (IL-4) and surface IL-4 receptor expression in patients with B-cell lymphocytic leukemia
21. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: Correlations with In vitro and In vivo chemoresponses
22. + T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection
23. Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemia
24. Interleukin-5 (IL-5) increases spontaneous apoptosis of B-cell chronic lymphocytic leukemia cells in vitro independently of Bcl-2 expression and is inhibited by IL-4
25. Effect of anti-APO1 on spontaneous apoptosis of B cells in chronic lymphocytic leukaemia: The role of Bcl-2 and interleukin-4
26. Cytokine receptors and B cell functions. I. Recombinant soluble receptors specifically inhibit IL-1 and IL-4-induced B cell activity in vitro
27. Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukemia cells
28. Analysis of blood T-cell cytokine expression in B-chronic lymphocytic leukaemia: Evidence of increased levels of cytoplasmic IL-4 in resting and activated CD8 T cells
29. Regulation of B-CLL apoptosis through membrane receptors and Bcl-2 family proteins
30. Interleukin-4 inhibits apoptotic cell death and loss of the Bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro
31. Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance
32. Elevated Bcl-2/Bax are a consistent feature of apoptosis resistance in B-cell chronic lymphocytic leukaemia and are correlated with in vivo chemoresistance
33. Chlorambucil resistance in B-cell chronic lymphocytic leukaemia is mediated through failed Bax induction and selection of high Bcl-2-expressing subclones
34. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo
35. Production of cytokines by human B cells in health and disease
36. Normal and aberrant expression of cytokines in neoplastic cells from chronic lymphocytic leukemias
37. Preparation of CD8bright and CD8dim lymphocyte populations using two positive selection methods in tandem
38. Interleukin-4 prevents spontaneous in vitro apoptosis in chronic lymphatic leukaemia but sensitizes B-CLL cells to melphalan cytotoxicity
39. Molecular biology of chronic lymphocytic leukemia: Implications for therapy
40. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones
41. + T cells in human disease: Lymphokine patterns in leprosy
42. + T cells from allergic individuals is modulated by antigen concentrations and antigen-presenting cell type
43. The functional role of CD8+ T helper type 2 cells
44. + T cells from T cell receptor transgenic mice
45. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: Relationship between p53 gene mutation and Bcl-2/Bax proteins in drug resistance